Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Ferenc Folláth, H. Just, JGY Papp et al. · The Lancet · 2002 · 1.2K citations

Medicine, Cardiology, Pharmacology +12

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection

Thomas M. Ludden, Stuart L. Beal, Lewis B. Sheiner · Journal of Pharmacokinetics and Biopharmaceutics · 1994 · 308 citations

Computing, Biostatistics, Item Response Theory +12

Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium

Burkert Pieske, Maria Castell, Bodo Kretschmann et al. · Circulation · 1998 · 301 citations

Medicine, Cardiology, Pharmacology +17

Sustained Hemodynamic Effects of Intravenous Levosimendan

Matti Kivikko, Lasse Lehtonen, Wilson S. Colucci · Circulation · 2003 · 258 citations

Medicine, Pharmacology, Pharmacotherapy +17

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

Piero Pollesello, Martti Ovaska, Juha Kaivola et al. · Journal of Biological Chemistry · 1994 · 233 citations · Full text

Medicine, Molecular Biology, Pharmacology +15